Product Images Glyburide And Metformin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Glyburide And Metformin Hydrochloride NDC 57237-024 by Rising Health, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/250 mg (100 Tablets Bottle) - glymet fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/250 mg (100 Tablets Bottle) - glymet fig1

This text is a description of a medication called FRising. It is a combination of Glyburide and Metformin Hydrochloride USP used for treating diabetes. It is recommended to be stored at a temperature between 20°C to 25°C. The packaging is a container with a child-resistant closure, and it has 100 tablets. It is distributed by a company called Rising Health LLC. The text also includes some product codes and manufacturing information.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg/500 mg (100 Tablets Bottle) - glymet fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg/500 mg (100 Tablets Bottle) - glymet fig2

The Rising NDC 57237-024-01 medicine contains a combination of glyburide and metformin hydrochloride tablets. Each film-coated tablet contains 2.5 mg/500 mg of glyburide and metformin hydrochloride USP. The medicine's usual dosage is mentioned in the package insert which was revised on 122017. The medicine should be stored in a light-resistant container with a child-resistant closure. The medicine is distributed by Rising Health, LLC located in New Jersey. The code TS/DRUGS/19/1983 is associated with this medication. The given code is the Over Printing Zone Coding Area of size 45x 15 mm. The temperature for storing the medicine should be between 20° to 25°C and excursions are permitted from 15° to 30°C.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg/500 mg (100 Tablets Bottle) - glymet fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg/500 mg (100 Tablets Bottle) - glymet fig3

Rising NpC 57237-025-01 is a medication consisting of the combination of Glyburide and Metformin Hydrochloride in USP film-coated tablets, with each tablet containing 5mg/500mg of the active ingredients. The usual dosage can be found in the package insert. The tablets should be stored in the range of 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication is dispensed with a child-resistant container. Rising Health, LLC, based in Saddle Brook, NJ, distributes this medication. There is also a printing zone within the label.*

Glyburide Chemical Structure - glymet str1

Glyburide Chemical Structure - glymet str1

Metformin Hydrochloride Chemical Structure - glymet str2

Metformin Hydrochloride Chemical Structure - glymet str2

The text seems to be a chemical compound formula indicating the Metformin Hydrochloride molecules. The symbol b (=) might indicate a bond or a link between the atoms. The other texts appear to be abbreviations of chemical elements such as NH (Nitrogen and Hydrogen), T, and HCI (Hydrochloric acid). Therefore, this description could be interpreted as a formula for the Metformin Hydrochloride compound.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.